E rectile dysfunction (ED) is characterized by the inability to develop or maintain penile erection during sexual activity.
NOX1 expression is consistently reported in vascular cells from animal models of cardiovascular and metabolic diseases, such as arterial hypertension, atherosclerosis, hypercholesterolemia, and DM. 18, 19 However, it is not clear whether abnormal NOX1 activity plays a role in DM-associated ED.
Nuclear factor E2-related factor 2 (Nrf2) is the main mediator of cellular adaptation to redox stress, that is, is the main negative regulator of oxidative stress. Nrf2 signaling activates the transcription of many key antioxidant genes, such as heme oxygenase-1, NAD(P)H:quinone oxidoreductase 1, glutathione S-transferase, and glutathione peroxidase. Under basal conditions, the protein Keap1 interacts with Nrf2 in the cytoplasm, keeping Nrf2 inactivated. Cellular stressors, such as ROS, lead to oxidation of cysteine residues in Keap1, inducing Nrf2 release and translocation into the nucleus. Nrf2 binds to antioxidant response element in the upstream promoter region of many antioxidant genes, promoting their transcription. [20] [21] [22] Therefore, considering that NADPH oxidase and Nrf2 signaling have been identified as the main vascular source and negative regulator of ROS, respectively, that NOX1 is involved in DM-associated vascular complications, and that alterations in function and structure of IPA lead to ED, we hypothesized that downregulation of Nrf2-regulated enzymes, consequent to increased NOX1-derived ROS, impairs IPA function in diabetic mice.
Materials and Methods
Expanded Materials and Method section is available in the onlineonly Data Supplement.
Animals and Experimental Model of DM
The study is in accordance with the Ethical Principles in Animal Research adopted by the National Council for the Control of Animal Experimentation and was approved by the Local Animal Ethical Committee from the School of Medicine of Ribeirao Preto of the University of Sao Paulo (protocol 068/2013). In addition, the studies were conducted in accordance with the Animals Scientific Procedures Act 1986. Male, C57BL/6 and NOX1 knockout (KO) mice were housed in individual cages in a room with controlled humidity and temperature and light/dark cycles of 12 hours. Animals had free access to food and potable tap water. To induce type-1 DM, 10-week-old C57BL/6 mice received intraperitoneal injections of streptozotocin (Sigma Aldrich; 50 mg/kg/d for 5 days). Blood glucose concentration was measured weekly (for 4 weeks) from the day of streptozotocin first injection. Blood samples were obtained weekly by nicking the lateral tail vein using a sterile scalpel blade.
Functional Studies in IPA
Internal pudendal arteries were cut into 2-mm ring segments and mounted on a wire myograph, as previously described. 23 After 60 minutes of stabilization, the contractile ability of the preparations was assessed by adding KCl solution to the organ baths. Endothelium integrity was verified by relaxation induced by acetylcholine (10 -6 mol/L; Sigma Aldrich) in IPA contracted with phenylephrine (10 -6 mol/L; Sigma Aldrich). To determine endothelium-dependent vasodilatation, acetylcholine was used in vessels precontracted with the thromboxane A2 analogue U46619 10 -6 mol/L (Tocris).
Isolation of VSMCs From IPA
VSMC were dissociated by digestion of arteries with enzymatic solution and cultured as we described. 24 Before experimentation, cell cultures were rendered quiescent by serum deprivation (0.5% FBS). Low-passage cells (passages 4-7) were used in our experiments.
Lucigenin-Enhanced Chemiluminescence
VSMC from IPA were stimulated with high glucose (HG) medium (25 mmol/L) at different time points-from 15 minutes to 24 hours. In some experiments, cells were pre-exposed to ML171. After stimulation, cells were washed and harvested in lysis buffer. NADPH (10 −4 mol/L) was added to the suspension containing lucigenin (5 μmol/L). Luminescence was measured before and after stimulation with NADPH. A buffer blank was subtracted from each reading. The results are expressed as percentage of control, in arbitrary units per microgram of protein, as measured by the Bradford assay.
Amplex Red
Measurement of vascular hydrogen peroxide (H 2 O 2 ) levels was performed using the fluorescence assay Amplex Red Hydrogen Peroxide/Peroxidase Assay Kit (Molecular Probes), according to the manufacturer's instructions. Cellular protein levels, measured by Bradford assay, were used to normalize H 2 O 2 production. The results are expressed in arbitrary units per milligram protein.
Nrf2 and Rho Kinase Activity
To determine nuclear accumulation of Nrf2, nuclear cell lysates were separated using the Active Motif nuclear extract kit (Active Motif, Carlsbad, CA) following the manufacturer's protocol. Rho kinase activity was measured with a Rho Kinase Activity Assay Kit (Cell Biolabs).
Immunoblotting
Quiescent VSMC were stimulated with HG and proteins extracted, separated by electrophoresis on a polyacrylamide gel, and transferred to a nitrocellulose membrane. Nonspecific binding sites were blocked with 5% bovine serum albumin in Tris-buffered saline solution. Membranes were then incubated with specific antibodies overnight at 4°C. Membranes were washed 3× with TBS-Tween 20 and incubated with specific secondary antibodies for 1 hour at room temperature. Signals were revealed after reaction with enhanced chemiluminescence. Results were normalized by the total protein content and are expressed relatively to control (100%) in the experimental protocols.
Protein Oxidation
Levels of protein-tyrosine phosphatases (PTPs) and peroxiredoxin oxidation were evaluated by Western blot and carbonylation by oxyblot assay (Millipore). VSMCs isolated from C57BL/6 and NOX1 KO mice were stimulated with HG medium, and levels of protein oxidation were measured.
Real-Time Polymerase Chain Reaction
Briefly, total RNA extracted from VSMC (Trizol) was treated with RNase-free DNase I, and 2 μg of RNA was reverse-transcribed in a reaction containing oligo dT. For real-time polymerase chain reaction amplification, 2 μL of each reverse transcription product were diluted in a reaction buffer containing 5 μL SYBR Green polymerase chain reaction master mix and 900 nmol/L primers in a final volume of 10 μL per sample. Data were analyzed by the 2 ∆∆Ct method, and the results expressed relatively to control.
Statistical Analysis
Data are presented as mean±standard error of the mean (SEM). Statistical comparisons were made with 1-way analysis of variance followed by Tukey's post test or 2-tailed Student's t test when appropriate. P<0.05 was considered statistically significant.
Results

IPA Dysfunction in Diabetic Mice Is Reversed by Tiron and ML171
Streptozotocin increased blood glucose levels ( Figure S1A ) within the first week of treatment, which was followed by a decrease in body weight ( Figure S1B ).
IPA isolated from diabetic mice exhibited increased phenylephrine-induced constriction (Figure 1 ), which was abrogated by Tiron, an ROS scavenger ( Figure 1B) , and by ML171, a NOX1 inhibitor ( Figure 1C ). Decreased acetylcholine-induced dilation was also observed in IPA from diabetic mice ( Figure S2A ), which was reversed by Tiron ( Figure S2B ) and ML171 ( Figure S2C ).
NOX1 Contributes to HG-Induced ROS Generation in IPA VSMC
In DM, vascular cells are constantly exposed to high concentrations of glucose. To determine molecular mechanisms involved in NOX1-associated IPA dysfunction in diabetic animals, VSMCs isolated from IPA of C57BL/6 and NOX1 KO mice were exposed to HG medium (25 mmol/L D-glucose). Preliminary experiments with IPA VSMC exposed to HG at different time points-from 15 minutes to 24 hours-demonstrated ROS generation after 2, 4, and 16 hours. Therefore, for further experiments, ROS generation was determined after exposure of IPA VSMC to HG medium (25 mmol/L) for 2 and 16 hours ( Figure S3A ). As observed in Figure 
NOX1 Contributes to HG-Induced Protein Oxidation in IPA VSMC
ROS generation modulates many vascular processes via oxidation of proteins, such as PTPs. ROS also influence phosphorylation of PTPs, thereby, modulating activity of PTPs. PTP oxidation, which renders the enzymes inactive, was increased in IPA VSMCs maintained in HG for 2 hours ( Figure 3A) , an effect not observed in NOX1 KO cells. Peroxiredoxin oxidation ( Figure 3B and 3C), as well as carbonylation ( Figure 3D and 3E), another type of irreversible oxidation induced by oxidative stress, was also increased in HG-treated VSMCs from C57BL/6, but not in NOX1 KO cells.
HG Downregulates Nrf2 Signaling in IPA VSMC
Considering that Nrf2 signaling is a major regulator of endogenous antioxidant systems, we evaluated whether HG interferes with Nrf2 signaling in IPA VSMCs. HG decreased nuclear accumulation of Nrf2 ( Figure 4A ), as well as total levels of Nrf2 ( Figure S3C ) in IPA VSMCs from C57BL/6 mice, which was followed by a decrease in mRNA expression of Nrf2-regulated enzymes ( Figure 4B ), such as catalase, heme oxygenase-1, NAD(P)H:quinone oxidoreductase 1, and peroxiredoxin, events not observed in IPA VSMC isolated from NOX1 KO mice ( Figure 4C and 4D) , indicating that the process is regulated by NOX1. NOX1 inhibition by ML171 also reversed the decrease in Nrf2-regulated enzymes induced by HG in IPA VSMC from C57BL/6 mice ( Figure S4 ). In addition, activation of the Nrf2 system by L-sulforaphane and bardoxolone decreased HG-induced ROS generation in IPA VSMC from C57BL/6 ( Figure 4E ) and abrogated IPA dysfunction in diabetic mice ( Figure 4F ), respectively.
ROS generation by endothelial cells, as well as decreased nuclear accumulation of Nrf2 induced by HG, was abrogated by NOX1 inhibition and Nrf2 activation ( Figure S5A and S5B). Activation of Nrf2 by bardoxolone also reversed reduced endothelium-dependent vasodilatation in diabetic mice ( Figure S5C ). 
NOX1 Contributes to HG-Induced Rho Kinase Activation in IPA VSMC
To determine molecular mechanisms by which NOX 1-derived ROS induce IPA dysfunction, vascular reactivity was evaluated in the presence of Y27632, an inhibitor of the redox-sensitive protein Rho kinase, which modulates vasoconstriction. The Rho kinase inhibitor abrogated increased vasoconstriction to phenylephrine in diabetic mice ( Figure 5A ). To determine the involvement of NOX1 in Rho kinase activation, VSMC isolated from C57BL/6 and NOX1 KO mice were maintained in HG. In basal conditions, Rho kinase activity was downregulated in cells isolated from NOX1 KO mice, and HG increased Rho kinase activity only in cells from C57BL/6 mice ( Figure 5B ), but not in VSMC from NOX1 KO mice. Similar results were found in the analysis of phosphorylation levels of the Rho kinase target, myosin phosphatase target subunit 1 ( Figure 5C ), a regulatory subunit of protein phosphatase 1.
Discussion
Major findings from the present study demonstrate that in DM, a condition associated with vascular oxidative stress, (1) IPA function is abnormal, (2) Nrf2 signaling and Nrf2-regulated antioxidant enzymes are downregulated through mechanisms involving NOX1-derived ROS, (3) activation of Nrf2 signaling or inhibition of NOX1 restores IPA function, and (4) NOX1-derived ROS leads to protein oxidation and IPA dysfunction via activation of the Rho Kinase pathway. These findings indicate that dysregulation in NOX1-derived ROS and Nrf2-antioxidant system contributes to oxidative stress and are associated with IPA dysfunction in DM. Decreased Nrf2 activation and increased NOX1-derived ROS impact IPA function in diabetic mice, which are normalized by Nrf2 activators and NOX1 inhibition. The vasoprotective actions of these drugs may be clinically important in DM-associated ED, where IPA function and structure are compromised.
Experimental and clinical evidence suggests an important role for ROS in DM-associated complications. Glucosestimulated ROS generation in human aortic endothelial cells is attenuated by siRNA targeted against NOX1 and by treatment with GKT137831, a NOX inhibitor. In addition, development of atherosclerosis in diabetic animals is reduced by deletion of NOX1 or treatment of apolipoprotein E −/− mice with GKT137831. 25 Treatment of obese and diabetic db/db mice with NOX inhibitors also reduces albuminuria, oxidative stress (TBARS levels), renal ERK1/2 (extracellular signal-regulated kinase) phosphorylation, and fibrosis. 26 Additional studies have shown the potential use of ROS scavengers in salvaging erectile function in diabetic condition. 27, 28 In corpora cavernosa from streptozotocin-induced diabetic rats, antioxidant treatment improves superoxide dismutase activity, increases endothelial nitric oxide synthase expression, and reduces ROS generation in corpora cavernosa, followed by an improvement in intracavernosal pressure/mean arterial pressure ratio. 29 Despite the evidence that DM is an important risk factor for ED, little is known about IPA function in diabetic conditions, and even less is known about the involvement of any catalytic core subunit of NOX, such as NOX1, in IPA function in DM. Our results reinforce an important role of ROS in
Figure 2. High glucose (HG)-induced reactive oxygen species (ROS) generation is not observed in nicotinamide adenine dinucleotide phosphate oxidase 1 (NOX1) knockout (KO) vascular smooth muscle cells (VSMC). The experiments were performed in VSMC isolated from internal pudendal arteries (IPA) of C57BL/6 (A-C) and NOX1 KO (D-F) mice, in basal conditions (control) or after exposure to HG (for 2 and 16 h). ROS generation was measured by lucigenin (A and D), peroxinitrite by nitrotyrosin assay (B and E), and H 2 O 2 levels by amplex red (C and F). The values were normalized by the amount of protein. Bars represent the mean±SEM (n=6-8). *P<0.05 vs control.
DM-associated IPA dysfunction because the absence of NOX1 or NOX1 inhibition reduced ROS generation, prevented activation of Rho kinase signaling, and restored vascular function. Of importance, NOX1 inhibition reversed DM-induced downregulation of the major antioxidant regulator, Nrf2. Decreased Nrf2 expression may account for the reduced Nrf2 nuclear accumulation. NOX1 inhibition may facilitate nuclear accumulation of Nrf2 in hyperglycemic states by decreasing Nrf2 degradation. Many mechanisms have been suggested as regulators of Nrf2 levels, such as the classic canonical mechanism (Keap1), 30 the redox-insensitive degron within the Neh6 domain of Nrf2, 31 and suppression of Nrf2 via Hrd1 E3 ubiquitin ligase. 32 Other proteins, such as DPP3 (dipeptidyl peptidase 3), and the positive regulator of Nrf2, p62 protein, compete with Nrf2 for Keap1 binding, thus stabilizing Nrf2. 33 In addition, NOX1 knockdown prevented HG-induced decreased H 2 O 2 levels in IPA VSMC. Considering the beneficial effects of H 2 O 2 , 34-36 the decrease in H 2 O 2 levels after HG exposure points out to additional mechanisms by which DM induces vascular damage. We have not determined which signal is responsible for NOX1 activation in IPA VSMCs stimulated with HG or whether NOX1 is the primary point or is activated by a preceding signal induced, for example, by advanced glycation end products or a metabolic product of HG conversion. Additional studies are needed to clarify these questions.
Supporting our results, other studies have shown that Nrf2 is dysregulated in experimental models of DM, whereas Nrf2 activation has protective effects. Zheng et al 37 demonstrated that Nrf2 activators reduce renal injury and improve the metabolic profile in a model of streptozotocin-induced DM. In diabetic kidneys, treatment with L-sulforaphane reduced oxidative stress, expression of the profibrotic mediator transforming growth factor-β, and extracellular matrix proteins, effects not observed in Nrf2-deficient diabetic animals, which reinforces L-sulforaphane specificity. 37 In mesenteric arteries from db/db mice, decreased Nrf2 activity contributes to increased ROS generation and increased vasoconstriction. Treatment with L-sulforaphane lowered ROS levels in db/db mice and reduced myogenic tone to levels comparable to those in vessels from control animals. 38 However, some studies demonstrated deleterious effects of Nrf2. The Nrf2 activator bardoxolone worsened proteinuria, glomerulosclerosis, and tubular damage in a model of type 2 DM, 39, 40 as well as renal function in a phase II clinical trial. 41 In addition, a trial was prematurely terminated because of higher incidence of heart failure and mortality in bardoxolone-treated patients. 42 Additional studies demonstrated that although low doses of Nrf2 activators are protective, high doses lead to deleterious outcomes. 40, 43 In basal conditions, Keap1, which regulates Nrf2 ubiquitination via Cul3-Keap1, keeps Nrf2 in the cytosol. In oxidative stress conditions, it is expected that Cul3-Keap1-E3 ligase is inhibited by oxidation, releasing Nrf2, which translocates to the nucleus, binds to antioxidant response element, and initiates transcription of antioxidant enzymes. 44, 45 However, in diabetic conditions, Nrf2 signaling is impaired, as observed by decreased nuclear accumulation of Nrf2 in IPA VSMC by guest on September 25, 2017 http://hyper.ahajournals.org/ Downloaded from exposed to HG medium. As a result, HG induces NOX1-derived ROS generation, but Nrf2 translocation and expression of antioxidant enzymes regulated by this pathway are decreased. Interestingly, NOX1 regulates these processes because in VSMC from NOX1-deficient mice, nuclear accumulation of Nrf2 was preserved on exposure to HG.
ROS are intracellular signaling molecules that modulate several cellular responses, such as inhibition of PTPs via oxidation of conserved cysteine residues. 46 The nucleophilic property of PTPs needed for substrate dephosphorylation is inhibited by oxidation, which renders these enzymes inactive. 47 In this study, we explored the potential of irreversible oxidation as a mechanism for regulation of PTP function. Stimulation of IPA VSMC cells with HG increased ROS generation and concomitantly inhibited PTPs, effects not observed in cells isolated from NOX1 KO animals, confirming that PTPs abnormalities are caused by NOX1-induced intracellular oxidation. The inactivation of PTPs in IPA VSMCs likely promotes augmented phosphorylation of various signaling proteins, which can contribute to DM-associated IPA dysfunction. A few studies corroborate our results. VSMC isolated from mesenteric artery from WKY (Wistar Kyoto) and SHRSP (spontaneously hypertensive stroke prone rat) rats 48 and retinal from rats and mice 49 exposed to hyperglycemia present increased expression of the PTP, PTP1B, Protein carbonylation is a post-translational modification where carbonyl groups are introduced into proteins. It is considered a biomarker for oxidative stress-induced irreversible damage and leads to loss of protein function. 50 HG-induced protein carbonylation in IPA VSMC from C57BL/6 mice is regulated by NOX1 because this was not observed in cells from NOX1 knockout animals. Of importance, peroxiredoxin was also targeted by HG-induced oxidation via NOX1. Hyperoxidation of peroxiredoxin leads to its inactivation, 51 which makes IPA VSMC vulnerable to damage associated with oxidative stress. More studies are needed to determine the involvement of carbonylation and oxidation of peroxiredoxin and PTPs and, consequently, augmented phosphorylation of proteins in IPA dysfunction. These proteins may represent targets in ED associated with impaired IPA function.
Several signaling proteins that modulate vascular reactivity, including the regulatory myosin binding subunit in myosin light chain phosphatase, are regulated by oxidative stress. The classical Rho kinase signaling involves phosphorylation of myosin phosphatase target subunit 1, which decreases the ability of myosin light chain phosphatase to dephosphorylate myosin light chain, thereby maintaining vascular contractility. 52 However, additional Rho kinase actions have been proposed. Inhibition of Rho kinase by fasudil reverses hypercholesterolemia-induced downregulation of Nrf2-regulated enzymes, such as catalase, glutathione peroxidase, and superoxide dismutase in rats. 53 Fasudil also reverses stroke-associated increased superoxide anion levels in endothelial cells, 54 suggesting a cross talk between Rho kinase and redox signaling. Regarding a role for Nrf2/Rho kinase in the erectile function process, it has been reported that increased Rho kinase activity contributes to impaired corpora cavernosa relaxation in streptozotocin-induced DM 55 and also in db/db mice, an experimental model that exhibit downregulation of Nrf2-regulated antioxidant enzymes. 56 Rho kinase inhibition also reduces ET-1-mediated IPA constriction in type 2 diabetic female rats 12 and increases intracavernosal pressure and rat penile erection induced by cavernous nerve stimulation. 57 Our data showing that Rho kinase activation in IPA from diabetic mice is an event regulated by NOX1-derived ROS further highlight the relevance of IPA-Nrf2/Rho kinase in the erectile function process and indicate that NOX1 inhibitors and Nrf2 activators may be important candidates to treat ED associated with Rho kinase-induced IPA dysfunction.
In conclusion, NOX1-derived ROS leads to IPA dysfunction via Nrf2 downregulation and Rho kinase activation in diabetic mice. These findings suggest that NOX1 activation, or blunting of Nrf-2 signaling, contributes to reduced antioxidant potential, increased oxidative stress and protein oxidation, and IPA dysfunction in diabetic animals. Normalization of these alterations by Nrf2 agonists may have therapeutic potential in IPA dysfunction and ED in DM ( Figure 6 ).
Perspectives
DM is associated with cellular and vascular dysfunction induced by failure of defences against oxidative stress. Increased NOX1 expression is consistently reported in vascular dysfunction in models of cardiovascular and metabolic diseases. Nrf2 via regulation of the expression of antioxidant enzymes is involved in protection against oxidative stress. Our results identify vasoprotective effects of Nrf2 agonists in IPA, which may have therapeutic potential in DM-associated ED. . Streptozotocin injec ons in C56BL/6 mice increase blood glucose levels and decrease body weight. Blood glucose concentra on (A) and body weight (B) were measured weekly (for 4 weeks) from the day of STZ injec on. Blood samples were obtained by nicking the lateral tail vein using a sterile scalpel blade. IPA VSMC were s mulated with L-glucose (osmo c control) and ROS genera on was measured by lucigenin (C). Blot to NOX1 was performed to confirm the absence of NOX 1 protein in VSMC isolated from NOX1 KO mice (D). Bars represent the mean ± SEM (n = 6). * p<0.05 vs. Control.
